Life sciences—Brexit tracker
Life sciences—Brexit tracker

The following Life Sciences guidance note provides comprehensive and up to date legal information covering:

  • Life sciences—Brexit tracker
  • Brexit SIs—commencement
  • Legislation
  • Regulatory guidance
  • UK government policy papers, documents and consultations
  • UK parliament inquiries, briefing papers and updates
  • Industry and independent reports
  • Relocation of the EMA

This Practice Note is intended to be used to track key developments and guidance related to Brexit in the life sciences sector.

Jump to:

  1. Legislation

  2. Regulatory guidance

  3. UK government policy papers, documents and consultations

  4. UK parliament inquiries, briefing papers and updates

  5. Industry and independent reports

  6. Relocation of the EMA

For more information and considerations on the key issues that are likely to affect the life science sector as a result of Brexit, see Practice Note: Brexit—implications of the Withdrawal Agreement for the life sciences sector.

To follow the timeline of the Brexit process, see Practice Note: Brexit timeline; to track the progress of UK legislation introduced as part of the legislative preparation for the UK’s withdrawal from the EU, see Practice Note: Brexit legislation tracker.

On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU law. Transitional provisions in the UK legislation implementing the Withdrawal Agreement, namely the European Union (Withdrawal Agreement) Act 2020 (EU(WA)A 2020) therefore amend the European Union (Withdrawal) Act 2018 (EU(W)A 2018) so that EU law continues to take effect in accordance with the Withdrawal Agreement during this time. For further information, see Practice Note: Brexit—introduction to the Withdrawal Agreement.

Brexit SIs—commencement

This Practice Note contains details of a number of